Belgian biotech developing a cryotherapy catheter system to treat inflamed atherosclerotic plaque and prevent heart attacks.
| Date | Round | Amount |
|---|---|---|
| Apr 2024 | Series B CryoTherapeutics raised a EUR10M Series B extension (equity plus non-dilutive) led by Noshaq to advance clinical evaluation of its cryotherapy catheter system. | $10.8M |